0 of 5 questions completed
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Time has elapsed
Thank you, we will review your submission and notify you of your results via email.
If not received within 5 hours due to spam, don’t worry, it will show in your profile.
1. After stenting, DAPT is necessary. Which risk does DAPT increase for the patients?
2. After what age is one considered a high bleeding risk patient?
3. What are the guidelines, set out by the ESC for the HBR patients, who present with stable coronary artery disease, and require PCI?
4. Biotronik’s extensive clinical program, with over 55 000 patients enrolled, includes which of the following trials for short term DAPT with Orsiro and Orsiro Mission:
5. Orsiro Mission has specific indication for HBR patients: